Patients HCPs
This site is for US residents only.
Purple to pink gradient background

Changes in coverage or loss of insurance? We can help. Here’s what to do to avoid a disruption in your treatment.

If your insurance plan has changed their coverage of COSENTYX® (secukinumab), it may be due to a change to their prescription drug formulary list. Most insurance plans have a list of preferred and covered medications called a formulary. This list may be re-evaluated every year based on a number of factors, including cost, safety, and effectiveness of the medication. In some instances, the insurance plan might remove COSENTYX from their formulary and exclude it from coverage, which may force a non-medical change to another medication. A change to your medication for a non-medical reason, especially during the COVID-19 pandemic, may be challenging. If it’s important to you to stay on COSENTYX, a medication you and your doctor decided is the best choice for you, here are steps you can take.

If your insurance coverage has changed:

One Icon

Call your insurance company and tell them you want to stay on COSENTYX. Ask for information about filing a medical exception and how soon this can be submitted so your COSENTYX coverage doesn’t end. A medical exception can be based on:

  • Any prior medications you have taken for your condition

  • How long you have been on COSENTYX

  • Satisfaction with your results

  • Your concern about unnecessary doctor visits during the COVID-19 pandemic

Second Icon

Tell your doctor that you want to stay on COSENTYX and ask your doctor to submit a medical exception to your insurance plan. You can help your doctor by providing the date your insurance plan will be ready to accept your medical exception submission.

To help ensure that you don’t miss a dose of COSENTYX due to this change, your doctor may be able to write a prescription for a 90-day supply of COSENTYX. If this is not possible, your doctor may be able to help you with other options to stay on COSENTYX.

Novartis Patient Assistance Foundation

The Novartis Patient Assistance Foundation, Inc. (NPAF), a non-profit organization, is committed to providing access to Novartis medications for those most in need. If you are experiencing financial hardship, have limited or no prescription coverage, and cannot afford the cost of your medication, then you may be eligible to receive Novartis medications for free. To learn more, call 1-800-277-2254 or visit www.PAP.Novartis.com.

Helping Hands

"My doctor said that my insurance was tough, but that COSENTYX® Connect would help me understand my options, and they did. COSENTYX works for me. Four years and counting."

COSENTYX psoriasis patient Dewey

Individual results may vary. Dewey was compensated for his time.

*Program Terms & Conditions: Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Patient is responsible for any costs once limit is reached in a calendar year. Program not valid (i) under Medicare, Medicaid, TRICARE, VA, DoD, or any other federal or state healthcare program, (ii) where patient is not using insurance coverage at all, (iii) where the patient’s insurance plan reimburses for the entire cost of the drug, or (iv) where product is not covered by patient’s insurance. The value of this program is exclusively for the benefit of patients and is intended to be credited towards patient out-of-pocket obligations and maximums, including applicable co-payments, coinsurance, and deductibles. Program is not valid where prohibited by law. Patient may not seek reimbursement for the value received from this program from other parties, including any health insurance program or plan, flexible spending account, or healthcare savings account. Patient is responsible for complying with any applicable limitations and requirements of their health plan related to the use of the Program. Valid only in the US and Puerto Rico. This Program is not health insurance. Program may not be combined with any third-party rebate, coupon, or offer. Proof of purchase may be required. Novartis reserves the right to rescind, revoke, or amend the Program and discontinue support at any time without notice.

†The Covered Until You're Covered Program is available for COSENTYX subcutaneous injection only. Eligible patients must have private insurance, a valid prescription for COSENTYX, and a denial of insurance coverage based on a prior authorization request. Program requires the submission of an appeal of the coverage denial within the first 90 days of enrollment in order to remain eligible. Program provides COSENTYX for free to eligible patients for up to two years, or until they receive insurance coverage approval, whichever occurs earlier. A valid prescription consistent with FDA-approved labeling is required. Program is not available to patients whose medications are reimbursed in whole or in part by Medicare, Medicaid, TRICARE, or any other federal or state program. Patients may be asked to reverify insurance coverage status during the course of the program. No purchase necessary. Program is not health insurance, nor is participation a guarantee of insurance coverage. Limitations may apply. Enrolled patients awaiting coverage for COSENTYX after two years may be eligible for a limited Program extension. Novartis Pharmaceuticals Corporation reserves the right to rescind, revoke, or amend this Program without notice.

*Limitations apply. Valid only for those with private insurance. Program provides up to $16,000 annually for the cost of COSENTYX and up to $150 per infusion (up to $1,950 annually) for the cost of administration. Co-pay support for infusion administration cost not available in Rhode Island or Massachusetts. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.